The Pennant Group, Inc. Common Stock (PNTG) is a publicly traded Healthcare sector company. As of July 14, 2026, PNTG trades at $39.90 with a market cap of $1.41B and a P/E ratio of 44.83. PNTG moved +0.10% today. Year to date, PNTG is +38.40%; over the trailing twelve months it is +57.99%. Its 52-week range spans $21.18 to $41.67. Analyst consensus is strong buy with an average price target of $41.25. Rallies surfaces PNTG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PNTG, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $39.90 |
| Market Cap | $1.41B |
| P/E Ratio | 44.83 |
| EPS | $0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.67 |
| 52-Week Low | $21.18 |
| Volume | 24 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.02B |
| Net Income | $35.53M |
| Gross Margin | 0.00% |
5 analysts cover PNTG: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.25.